[go: up one dir, main page]

CN1041992C - Preparation technology of cold resistant panacla tablet - Google Patents

Preparation technology of cold resistant panacla tablet Download PDF

Info

Publication number
CN1041992C
CN1041992C CN92106023A CN92106023A CN1041992C CN 1041992 C CN1041992 C CN 1041992C CN 92106023 A CN92106023 A CN 92106023A CN 92106023 A CN92106023 A CN 92106023A CN 1041992 C CN1041992 C CN 1041992C
Authority
CN
China
Prior art keywords
tablet
extract
radix isatidis
mixing
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92106023A
Other languages
Chinese (zh)
Other versions
CN1062088A (en
Inventor
潘浬
赵喆
闫桂珍
曲成基
胡秀芝
刘桂琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENYANG TRADITIONAL CHINESE M
Original Assignee
SHENYANG TRADITIONAL CHINESE M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENYANG TRADITIONAL CHINESE M filed Critical SHENYANG TRADITIONAL CHINESE M
Priority to CN92106023A priority Critical patent/CN1041992C/en
Publication of CN1062088A publication Critical patent/CN1062088A/en
Application granted granted Critical
Publication of CN1041992C publication Critical patent/CN1041992C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a technology for preparing a cold resisting tablet having the efficacy of fever relief, pain elimination and fire removal, which is characterized in that a certain quantity of the effective components of radix isatidis and chrysanthemums are extracted; then the effective components are sufficiently mixed with a certain quantity of extracts of berberine, extracts of asiatic moonseed rhizome, paracetamolum powder and artificial bezoar uniformly; a mixture is prepared into granules by ethanol, and the tablet is prepared finally. The present invention is suitable for common cold, nasal obstruction, rhinorrhea, pharyngeal portion gall, cough, headaches, sour pain in a whole body, long-lasting high fever and complications, such as antiaditis, lymphadenitis, etc., caused by the common cold. The present invention has the characteristics of simple technology, abundant medicine source, low cost and portability; furthermore, the tablet is combined and synthesized by Chinese medicines and Western medicines.

Description

Preparation technology of cold resistant panacla tablet
The present invention relates to a kind of Tabules oral medicine technical field, specifically a kind of employing Chinese medicine and western medicine combines, and has the production method of cold resistant tablet of the effect of analgesic, analgesia, antiinflammatory.
As everyone knows, the drug main that is directly used in the treatment human body diseases will divide two big classes, and a class is a Western medicine, and a class is a Chinese medicine.Along with the continuous development of science and technology, Chinese and Western two big class medicines begin to have interpenetrated in processing and application, for example: Chinese herbal medicine is utilized the Western medicine processing extraction technique, extract the active ingredient in the Chinese herbal medicine, and be processed into Chinese medicine unguentum or tablet.We know, use the western medicine curative effect of disease generally very fast, but toxic and side effects are also relatively large, and are just inapplicable to some patients like this; Treatment by Chinese herbs then generally has no side effect, but treatment cycle is longer, and is also inapplicable to the people that some state of an illness are heavier.Therefore, the method that some common medicines adopt Chinese medicine and western medicine to combine is made, just seemed important all the more more effectively to treat disease.
The purpose of this invention is to provide and a kind ofly have comprehensive drug and adopt Chinese medicine and western medicine to combine to produce the new technology of anticold tablet, address the problem of function singleness on existing to alleviate simple employing Western medicine or Chinese medicine.
Realize that the concrete technology characteristics of purpose of the present invention is;
1, the 35-50% that will account in the gross weight 35-40% Radix Isatidis that feeds intake is standby after pulverizing 100 mesh sieves;
2, decoct twice after getting the Flos Chrysanthemi mixing of the Radix Isatidis of surplus and 30-35%, for the first time adding 14 times of amounts of water boiled 1 hour, for the second time add 8 times of amounts of water and boil half an hour, merge filtrate twice, after filtration, leave standstill 12 hours after, draw supernatant, concentrating under reduced pressure becomes cream, and the proportion of cream is 1.25-1.30 (Baume hydrometer 70-80 ℃ measurement).
3, the Radix Isatidis after above-mentioned condensed cream and the pulverizing is stirred; after the drying; the XIAONIEGEN extract that adds 7-10%; the Rhizoma Menispermi extract of 4-7%; mixing and pulverized 100 mesh sieves after, be blended into the paracetamol powder of 10-14%, the artificial bezoar powder of 2-3%, fully make granule with ethanol behind the mixing; dry back is selected grain, is added the Pulvis Talci of prescription gross weight 1%, 0.6% magnesium stearate again, and tabletting, sugar coating are promptly behind the mixing.
The optimum weight percentage ratio of medicine that the present invention drops into is:
Artificial Calculus Bovis's 2.76% acetaminophen 11.51%
XIAONIEGEN extract 8.10% Radix Isatidis 38.57%
Rhizoma Menispermi extract 5.35% Flos Chrysanthemi 33.71%.
The present invention is owing to adopt Flos Chrysanthemi, Radix Isatidis, artificial Calculus Bovis, berberine, dauricine and acetaminophen etc. to develop, and therefore has effects such as analgesic, analgesia, antiinflammatory.In view of Flos Chrysanthemi is the wind heat clearing away of loosing, the suppressing the hyperactive liver medicine that makes eye bright, be used for anemopyretic cold, headache, dizzy, conjunctival congestion and swelling pain, hypertension, have the effect of tonifying YIN heat-clearing and toxic substances removing, influenza virus there is good inhibition effect; Radix Isatidis is the heat-clearing and toxic substances removing blood-cooling drugs, is used for epidemic febrile disease heating, anemopyretic cold, laryngopharynx swelling and pain, epidemic encephalitis type B etc., has good antibacterial action, and influenza, epidemic encephalitis, encephalitis b, scarlet fever are had good curative effect; Artificial Calculus Bovis, berberine and dauricine have clear away heart-fire, effect such as detoxifcation, anti-inflammatory analgetic; And acetaminophen can analgesic, analgesia.Therefore, medicament of the present invention all plays ideal therapeutic effect to various anemofrigid cold or anemopyretic cold.After taking medicine, not only alleviate General Symptoms, it is rapid to eliminate nose mucositis dress phenomenon, also effective to improving respiratory tract and symptom of digestive tract.The present invention is the Chinese medicine and western medicine mixture, has excavated the medical treasure-house of China, has used the characteristics of modern medicine.This medicine not only is better than the medicine of other treatment flu for the treatment flu, and has no side effect, and also can treat diseases such as upper respiratory tract infection, intrapulmonary infection, cholecystitis, urinary tract infection, rheumatism and tracheitis.Characteristics such as also to have processing technology simple in the present invention in addition, and abundant, with low cost, the synthetic tablet in medicine source is easy to carry.
Below in conjunction with accompanying drawing embodiment of the present invention are further described in detail.
Fig. 1 is a process flow diagram of the present invention.
Embodiment 1
Present embodiment is the technological process of adopting Fig. 1, with the dosage that to produce 1000 coated tablets be unit, wherein:
Artificial Calculus Bovis's 17 gram acetaminophen 71 grams
XIAONIEGEN extract 50 gram Radix Isatidis 238 grams
Rhizoma Menispermi extract 33 gram Flos Chrysanthemis 208 grams
Annotate: contained berberine hydrochloride must not be less than 70% in the XIAONIEGEN extract, and contained dauricine must not be less than 25% in the Rhizoma Menispermi extract.
Operational process of craft;
1, pulverize: get Radix Isatidis coarse fodder 103 grams, after pulverizing 100 mesh sieves, standby.
2, decoct: other gets Radix Isatidis coarse fodder 135 grams, Flos Chrysanthemi 208 grams, decoct twice, for the first time add 14 times of amounts of water and boiled 1 hour, add 8 times of water gagings for the second time and boil half an hour, filter, filtrate was left standstill 12 hours, draw the supernatant concentrating under reduced pressure and become cream, proportion is that the wet cream rate of 1.25-1.30 (Baume hydrometer 70-80 ℃ survey) is about 30%, and dried cream rate is about 20%.
3, pelletizing press sheet: condensed cream and Radix Isatidis powder are stirred, and dry (below 80 ℃) add XIAONIEGEN extract 50 grams then; Rhizoma Menispermi extract 33 grams stir and pulverized 120 mesh sieves, are blended into paracetamol powder (fineness requirement 100 orders) 71 grams again; artificial Calculus Bovis's 17 grams; make soft material with 95% ethanol behind the mixing, granulate dry (70-80 ℃), the choosing grain with 14 mesh sieves; 1% Pulvis Talci that adds total inventory again; 0.6% magnesium stearate, tabletting behind the mixing, sugar coating is finished product.

Claims (3)

1, a kind of preparation technology of cold resistant panacla tablet with effect of analgesic, analgesia, antiinflammatory is characterized in that:
(1), the 35-50% that will account in the gross weight 35-40% Radix Isatidis that feeds intake is standby after pulverizing 100 mesh sieves;
(2), decoct twice after getting the Flos Chrysanthemi mixing of the Radix Isatidis of surplus and 30-35%, for the first time adding 14 times of amounts of water boiled 1 hour, for the second time add 8 times of amounts of water and boil half an hour, merge filtrate twice, after filtration, leave standstill 12 hours after, draw supernatant, concentrating under reduced pressure becomes cream, and the proportion of cream is 1.25-1.30 (70-80 ℃ of measurement of ripple English gravimeter);
(3), the Radix Isatidis after above-mentioned condensed cream and the pulverizing is stirred; after the drying; the XIAONIEGEN extract that adds 7-10%; the Rhizoma Menispermi extract of 4-7%; mixing and pulverized 100 mesh sieves after, be blended into the paracetamol powder of 10-14%, the artificial bezoar powder of 2-3%, fully make granule with ethanol behind the mixing; dry back is selected grain, is added the Pulvis Talci of prescription gross weight 1%, 0.6% magnesium stearate again, and tabletting, sugar coating are promptly behind the mixing.
2, anticold tablet reparation technology according to claim 1 is characterized in that the percentage by weight of the medicine that drops into is:
Artificial Calculus Bovis's 2.76% acetaminophen 11.51%
XIAONIEGEN extract 8.10% Radix Isatidis 38.57%
Rhizoma Menispermi extract 5.35% Flos Chrysanthemi 33.71%.
3, preparation technology of cold resistant panacla tablet according to claim 1 and 2 is characterized in that: contained berberine hydrochloride must not be less than 70% in the XIAONIEGEN extract, and contained dauricine must not be less than 25% in the Rhizoma Menispermi extract.
CN92106023A 1992-01-16 1992-01-16 Preparation technology of cold resistant panacla tablet Expired - Fee Related CN1041992C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN92106023A CN1041992C (en) 1992-01-16 1992-01-16 Preparation technology of cold resistant panacla tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN92106023A CN1041992C (en) 1992-01-16 1992-01-16 Preparation technology of cold resistant panacla tablet

Publications (2)

Publication Number Publication Date
CN1062088A CN1062088A (en) 1992-06-24
CN1041992C true CN1041992C (en) 1999-02-10

Family

ID=4941723

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92106023A Expired - Fee Related CN1041992C (en) 1992-01-16 1992-01-16 Preparation technology of cold resistant panacla tablet

Country Status (1)

Country Link
CN (1) CN1041992C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1053582C (en) * 1996-05-27 2000-06-21 河北恒利集团公司 Medicine composition for curing cold
CN1069837C (en) * 1999-01-19 2001-08-22 谢宁灼 Drops for curing cold

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87104199A (en) * 1987-06-11 1988-01-06 哈尔滨市制药七厂 Preparation method of children's quick-acting cold spirit

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87104199A (en) * 1987-06-11 1988-01-06 哈尔滨市制药七厂 Preparation method of children's quick-acting cold spirit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《云南中国杂志》1987 年第3期 1987.1.1 郑新民,中医药防治感冒研究进展 *

Also Published As

Publication number Publication date
CN1062088A (en) 1992-06-24

Similar Documents

Publication Publication Date Title
CN101933991B (en) Analgesic and anti-inflammatory medicine and preparation method thereof
CN113288978A (en) Composition for treating gout and preparation method and application thereof
CN101569739B (en) Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof
CN111840456A (en) Chinese medicinal composition for treating respiratory system diseases
CN111358906B (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN1041992C (en) Preparation technology of cold resistant panacla tablet
CN1016141B (en) Preparation method of novel sanguisorba officinalis preparation
CN1404854A (en) Medicine for treating nosal inflammation
CN100411666C (en) Broad-specturm medicine for treating snake venom poisoning
CN1256134C (en) Medicinal composition for treating rheumatoid
CN101543523B (en) Uyghur drug compound recipe extracting technology for chiccory
CN1033210C (en) Process for preparing Chinese medicine to reinforce vital energy of kidney and relieve asthma
CN1951494B (en) Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof
CN1261130C (en) Medicine for dispelling tinea
CN106619870B (en) Composition for treating digestive system tumor and preparation method thereof
CN101199574A (en) Function of extract of boraginaceae cynoglossum furcatum class plant in preparing anti-inflammation analgesis medicament
CN108404059A (en) A kind of Chinese medicine composition for treating anti-type thyroid adenoma on liver-yang
CN102397508B (en) Application of Tibetan medicine composition in preparation of medicament for treating bronchial asthma
CN102058830B (en) Medicinal composition preparation and preparation method thereof
KR20190059531A (en) A chinese medicine for treating fatty liver and its preparation method
CN106310065A (en) Traditional Chinese medicine composition for treating urticaria and preparation method thereof
CN114569690A (en) Traditional Chinese medicine composition for treating helicobacter pylori infectious gastritis
CN104623050B (en) A kind of medicament for the treatment of corticosteroid femur head necrosis
CN114984179A (en) Composition for treating or preventing mitiglinide adverse reaction and preparation method and application thereof
CN104800339A (en) Traditional Chinese medicine composition for treating bone fracture

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee